Headquarters
801 ROSLYN TER, EVANSTON, IL 60201-1723, US
EVANSTON, IL, US
ENCUE INC.
From the company
ENCUE is a Northwestern spinout developing novel modulators and therapeutics for neurodegenerative and psychiatric disorders. Its approach targets synaptic function and neuroplasticity to restore synaptic health and normal cognition, with a focus on the IGF2R receptor. The company reports six molecules currently in Phase 2/3 clinical trials.
Products & services offered
Capabilities 4
Classifications
- Ownership classifications (1)
- Self Certified Small Disadvantaged Business
Facilities
Send your requirements
Quantities, certifications, and timing.